Overview
Caroline is a General Internist. Her clinical interests are in primary care for vulnerable populations and patients with multiple chronic conditions. Her research interests focus on the role that money plays in medical decision-making. She currently studies financial barriers to care for patients with multiple chronic conditions, the impact of recent price transparency regulations, and the ways that doctors and patients communicate about and make decisions based on out-of-pocket costs.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2021 - Present
Medicine, General Internal Medicine,
Medicine
Assistant Professor in Population Health Sciences
·
2021 - Present
Population Health Sciences,
Basic Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Initiatives & Academic Support Units
Recent Publications
Annals On Call - Health Expenditures of Patients With Diabetes After Bariatric Surgery.
Journal Article Ann Intern Med · April 2025 Full text Link to item CiteHealth Expenditures of Patients With Diabetes After Bariatric Surgery: Comparing Gastric Bypass and Sleeve Gastrectomy.
Journal Article Ann Intern Med · March 2025 BACKGROUND: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) differ in their effects on body weight and risk for reoperation. However, it is unclear whether long-term health expenditures differ by procedure type in patients with diabetes. OBJECT ... Full text Link to item CiteIntegrating Out-of-Pocket Costs Into Shared Decision-Making for Heart Failure With Reduced Ejection Fraction: A Stepped-Wedge Trial (POCKET-COST-HF).
Journal Article Circ Cardiovasc Qual Outcomes · January 2025 BACKGROUND: Guideline-directed medical therapy for heart failure (HF) with reduced ejection fraction can entail high out-of-pocket (OOP) costs, prompting concerns about financial toxicity and access. OOP costs are generally unavailable during encounters. T ... Full text Link to item CiteRecent Grants
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
ResearchPrincipal Investigator · Awarded by National Institute on Aging · 2023 - 2027Heterogeneity in Medication Therapy Management Used to Reduce Potentially Inappropriate Medication Use
ResearchCo Investigator · Awarded by University of Massachusetts Medical School · 2024 - 2025Development of a Financial Toxicity Measurement Tool for Patients with Multimorbidity
ResearchSignificant Contributor · Awarded by University of Massachusetts Medical School · 2023 - 2024View All Grants
Education, Training & Certifications
University of Pennsylvania, School of Medicine ·
2015
M.D.